Solace Therapeutics wins CE Mark for female incontinence device

October 1, 2009 by MassDevice staff

The Framingham, Mass.-based device maker's non-surgical intravesical system gets the OK to hit the market in the European Union.

Solace Therapeutics wins CE Mark for female incontinence device

Solace Therapeutics Inc. won CE Mark approval in the European Union for its intravesical system to treat female stress urinary incontinence.

The Framingham, Mass.-based medical device maker said its device is a small, quarter-sized balloon that floats inside the bladder. Inserted via catheter during an out-patient procedure, the balloon is designed to relieve the pressure fluctuations within the bladder that lead to incontinence.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp